HITK Financial Facts

Research and product development costs: 4.45M
Interest (income) and other: -509K
See Full Income Statement

Prepaid income taxes: 6.45M
Additional paid-in capital: 113.04M
See Full Balance Sheet

Hi Tech Pharmacal Co. Inc. (HITK) Earnings

  |   Expand Research on HITK
Next EPS Date N/A EPS Growth Rate +74.4% *Last Qtr.
Average EPS % Beat Rate +10.2% Revenue Growth Rate -6.9% *Last Qtr.
Average % Move 1-Wk after EPS +1.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/7/13 Q313 $0.43$0.71 -$0.28$64.33M$60.45M N/A Details
9/5/12 Q113 $0.44$0.68 -$0.24$52M$57.6M N/A Details
7/9/13 Q413 $0.50$0.63 -$0.13$58.5M$66.33M N/A Details
3/8/12 Q411 $0.79$0.87 -$0.08$55.63M$55.73M N/A Details
7/10/12 Q412 $0.73$0.78 -$0.05$61.3M$57.94M N/A Details
9/9/13 Q114 $0.44$0.44 $0.00$50.5M$57.78M N/A Details
12/6/12 Q213 $0.66$0.59 +$0.07$57.54M$56.89M N/A Details
3/11/14 Q314 $0.75$0.66 +$0.09$59.9M$62.35M N/A Details